News

Nov 2018

Rabies risk warning to travellers

Voluntary recall of Rabies Vaccine BP - April 2004

The Irish Medicines Board (IMB), the Department of Health and Children and the Health Protection Surveillance Centre (HPSC) have been notified that Aventis Pasteur MSD Ireland, as a precautionary measure, is voluntarily recalling two batches of Rabies Vaccine BP that have been supplied in Ireland.

Irish Medicines Board, Rabies Vaccine BP - Precautionary Recall of two batches - 7th April 2004

The Irish Medicines Board (IMB) stated today that it is in close consultation with the French authorities and Aventis Pasteur MSD Limited in relation to the worldwide recall of a rabies vaccine manufactured by the company's operations in France.

Recall of Rabies Vaccine Aventis Pasteur MSD: Batches X0071-6 and X0712-1, Advice to clinicians - 7th April 2004

Following discussions with The Irish Medicines Board, Aventis Pasteur MSD sent an alert to relevant healthcare professionals over recent days informing them of a recall of the above two batches of Rabies Vaccine BP (Aventis Pasteur MSD). A recent quality-assurance test identified the presence of non-inactivated Pitman-Moore virus (an attenuated vaccine strain) in a single product lot, which was not distributed.

Rabies risk warning to travellers

Voluntary recall of Rabies Vaccine BP - April 2004

Irish Medicines Board, Rabies Vaccine BP - Precautionary Recall of two batches - 7th April 2004

Recall of Rabies Vaccine Aventis Pasteur MSD: Batches X0071-6 and X0712-1, Advice to clinicians - 7th April 2004

Find a Topic

Publications

News